Google Chrome
Safari
Firefox
Edge
Press Release / May 07, 2026
Hovione and IDC Intranasal Drug Delivery Platform Available for Commercial Partnerships
Its lead single-use nasal dry powder device now available for commercial partnerships
Search
News / Sep 09, 2024
Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions
Hovione commitment to setting SBTs in line with the Paris Agreement
Continuous Tableting for Drug Product
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.
Press Release / Jan 17, 2023
Hovione is recognized as a Top Employer 2023
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Press Clipping / Oct 27, 2025
Hovione Completes Initial $100M Investment Cycle to Expand U.S. Operations at New Jersey Manufacturing Site
Innovations in Pharmaceutical Technology, IPT Online, 27 October 2025
Press Release / May 04, 2020
Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer
Effective May 1st, 2020